ENTPD1 and neoplasm: (24) demonstrated that CD39 marked a subset of tumor-infiltrating CD4+ T cells that exhibited an exhausted, immunosuppressive effector-memory phenotype, while, inhibiting CD39 enzymatic activity reinvigorated these CD4+ T cells, thereby enhancing their secretion of TNF-α and IFN-γ (24).